NLS Pharmaceutics
NLSP
NLSP
5 hedge funds and large institutions have $102K invested in NLS Pharmaceutics in 2022 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
50% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 4
Holders
5
Holding in Top 10
–
Calls
–
Puts
–
Top Sellers
| 1 | -$51K | |
| 2 | -$25K | |
| 3 | -$15K | |
| 4 |
VF
Virtu Financial
New York
|
-$12K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$3.06K |